William Blair Reaffirms Outperform Rating for Alnylam Pharmaceuticals (NASDAQ:ALNY)

William Blair reiterated their outperform rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research report released on Monday, RTT News reports. ALNY has been the subject of several other reports. JPMorgan Chase & Co. boosted their target price on shares of Alnylam Pharmaceuticals from $150.00 to $170.00 and gave the company […]

Related Keywords

William Blair ,Jpmorgan Chase Co ,Harbor Capital Advisors Inc ,Analyst Recommendations For Alnylam Pharmaceuticals ,Alnylam Pharmaceuticals Stock Down ,News Ratings For Alnylam Pharmaceuticals Daily ,Alnylam Pharmaceuticals ,Ep Wealth Advisors ,Citigroup ,Steward Partners Investment Advisory ,Alnylam Pharmaceuticals Inc ,Wells Fargo Company ,Morgan Stanley ,Bridgewater Associates ,Free Report ,Moderate Buy ,Pharmaceuticals Stock Down ,Get Free Report ,Capital Advisors ,Financial Advisors ,Partners Investment Advisory ,Alnylam Pharmaceuticals Daily ,